NASDAQ:DNLI   Denali Therapeutics Inc.
According to Zacks Equity Research, it shouldn't be surprising that CDNS is a #2 stock and boasts a Momentum Score of A. If you're looking for a fresh pick that's set to soar in the near-term, make sure to keep Cadence Design Systems on your short list.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.